U.S. Markets closed

Johnson & Johnson (JNJ)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
127.51-0.01 (-0.01%)
At close: 4:01PM EDT

127.80 0.29 (0.23%)
After hours: 4:51PM EDT

People also watch
PGMRKKOPFEXOM
Interactive chart
Previous Close127.52
Open127.79
Bid0.00 x
Ask0.00 x
Day's Range127.29 - 128.00
52 Week Range109.32 - 129.00
Volume3,967,529
Avg. Volume6,213,140
Market Cap343.49B
Beta0.67
PE Ratio (TTM)21.43
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.36 (2.64%)
Ex-Dividend Date2017-02-24
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press34 minutes ago

    Drugmaker paying $33M over recalled nonprescription meds

    Johnson & Johnson has reached a $33 million settlement with 42 states, resolving allegations the health care giant sold numerous nonprescription medicines that didn't meet federal quality requirements ...

  • TheStreet.com3 hours ago

    Johnson & Johnson Settles U.S. Drug Manufacturing Probe

    The $33 million settlement was announced by the attorney general on behalf of 42 states and the District of Columbia.

  • Reuters4 hours ago

    J&J settles drug manufacturing probe by U.S. states for $33 mln

    Johnson & Johnson has agreed to pay $33 million to resolve charges by most U.S. states that it misrepresented the manufacturing practices behind Tylenol, Motrin, Benadryl and other over-the-counter drugs that were eventually recalled. The list includes St. Joseph Aspirin, Sudafed, Pepcid, Mylanta, Rolaids, Zyrtec, and Zyrtec Eye Drops, the Illinois attorney general said in a news release. The company's Johnson & Johnson Consumer Inc unit must also ensure that its marketing and promotional practices do not unlawfully promote over-the-counter drug products, the attorneys general said.